Revolade 75 mg film-coated tablets -
Revolade 75 mg film-coated tablets -
Revolade est indiqué chez les patients adultes présentant une aplasie médullaire acquise sévère qui sont soit réfractaires à un traitement
Revolade Active substance Eltrombopag Holder Novartis Status Closed Indication patients aged 1 year and above with primary immune thrombocytopenia Revolade 50mg Tablet is a thrombopoietin agonist It works by stimulating the formation of new platelets in the blood The function of platelets is to help
dear lottery today prediction Revolade is the first approved therapy in the EU for patients with severe aplastic anemia who have not responded to other treatments Revolade 25mg Tablet is an antineoplastic, thrombopoietin receptor antagonist that inhibits the function of hematopoietic growth factors This tablet is used in
